abrdn Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$178M Buy
2,161,631
+68,164
+3% +$5.56M 0.6% 62
2017
Q1
$176M Sell
2,093,467
-140,711
-6% -$11.3M 0.58% 63
2016
Q4
$164M Buy
2,234,178
+435,774
+24% +$32.5M 0.57% 65
2016
Q3
$144M Buy
1,798,404
+389,164
+28% +$31.1M 0.59% 62
2016
Q2
$111M Buy
1,409,240
+111,777
+9% +$8.42M 0.5% 68
2016
Q1
$93.4M Sell
1,297,463
-123,709
-9% -$9.36M 0.43% 73
2015
Q4
$120M Buy
1,421,172
+46,511
+3% +$3.86M 0.51% 65
2015
Q3
$115M Sell
1,374,661
-108,855
-7% -$9.19M 0.49% 72
2015
Q2
$124M Buy
1,483,516
+1,035,356
+231% +$78.9M 0.52% 71
2015
Q1
$32.6M Buy
448,160
+92,391
+26% +$6.58M 0.13% 107
2014
Q4
$24.5M Buy
355,769
+123,721
+53% +$8.35M 0.1% 119
2014
Q3
$15.1M Buy
232,048
+55,148
+31% +$3.49M 0.06% 143
2014
Q2
$11M Buy
176,900
+133,325
+306% +$7.95M 0.05% 148
2014
Q1
$2.56M Sell
43,575
-86,400
-66% -$4.82M 0.01% 183
2013
Q4
$6.63M Buy
129,975
+87,481
+206% +$4.38M 0.04% 170
2013
Q3
$2.14M Sell
42,494
-463
-1% -$24.2K 0.01% 199
2013
Q2
$2.11M Buy
+42,957
New +$2.34M 0.01% 188

Other funds holding LLY

abrdn Investment Management's LLY Position: Q2 2017 in Review

abrdn Investment Management increased its Eli Lilly (LLY) stake by 3.3% in Q2 2017, buying an estimated $5.56M and bringing the position to 2,161,631 shares worth $178M. The position accounts for 0.6% of the portfolio, ranked #62.

abrdn Investment Management first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • abrdn Investment Management held 2,161,631 shares of Eli Lilly worth $178M as of Q2 2017.
  • abrdn Investment Management bought 68,164 Eli Lilly shares in Q2 2017, an estimated $5.56M.
  • Eli Lilly made up 0.6% of abrdn Investment Management's portfolio in Q2 2017, its #62 holding.
  • abrdn Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.